Literature DB >> 7041238

Mechanism of renin release during renal nerve stimulation in dogs.

H Holdaas, O Langård, I Eide, F Kiil.   

Abstract

During renal nerve stimulation, a predominant vasoconstrictory effect on small arteries would lower blood pressure in the afferent arterioles and induce arteriolar dilation and renin release by the autoregulation mechanism. This hypothesis was examined in anaesthetized dogs by stimulating renal nerves at 4 Hz which permitted continuous reduction of renal blood flow (RBF) by 30-40%; renin release increased almost equally at control and low blood pressure, and in the non-filtering kidney during ureteral occlusion. Examinations of the relationship between RBF and arterial perfusion pressure during mechanical constriction of the renal artery showed that the lowest autoregulating pressure was 25-35 mmHg higher during nerve stimulation than in control experiments, consistent with the hypothesis of arteriolar dilation. Phenoxybenzamine, an inhibitor of alpha-adrenoceptors, abolished vasoconstriction and the effect of nerve stimulation on renin release at control blood pressure; renin release rose from 0.9 +/- 0.4 to 17 +/- 5 microgram/min before, and from 1.7 +/- 0.5 to 4.6 +/- 1.4 microgram/min after phenoxybenzamine infusion. At pressures below the range of autoregulation, phenoxybenzamine did not alter renin release response to nerve stimulation. Propranolol, a Beta-adrenergic inhibitor, attenuated the effect of nerve stimulation on renin release both at control and low blood pressure. We conclude that during renal nerve stimulation (1) renin release is caused by beta-adrenergic stimulation provided the afferent arterioles are dilated and (2) that alpha-adrenergic stimulation dilated the afferent arterioles as a consequence of a predominant vasoconstrictory effect on small arteries. Hence, by inhibiting the beta-adrenergic effect by propranolol, renin release does not increase during renal nerve stimulation. Phenoxybenzamine prevents renin release at control blood pressure because afferent arterioles are not dilated during nerve stimulation. In contrast, phenoxybenzamine does not reduce renin release during nerve stimulation at low blood pressure because afferent arterioles are dilated by the autoregulating mechanism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7041238     DOI: 10.3109/00365518109090506

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  6 in total

1.  Resetting of renal autoregulation in conscious dogs: angiotensin II and alpha1-adrenoceptors.

Authors:  P B Persson; H Ehmke; B Nafz; H R Kirchheim
Journal:  Pflugers Arch       Date:  1990-09       Impact factor: 3.657

2.  Autoregulation of renal blood flow, glomerular filtration rate and renin release in conscious dogs.

Authors:  H R Kirchheim; H Ehmke; E Hackenthal; W Löwe; P Persson
Journal:  Pflugers Arch       Date:  1987-11       Impact factor: 3.657

3.  Resetting of pressure-dependent renin release by intrarenal alpha 1-adrenoceptors in conscious dogs.

Authors:  H Ehmke; P Persson; S Fischer; E Hackenthal; H Kirchheim
Journal:  Pflugers Arch       Date:  1989-01       Impact factor: 3.657

4.  Baroreflex sympathetic activation increases threshold pressure for the pressure-dependent renin release in conscious dogs.

Authors:  H R Kirchheim; R Finke; E Hackenthal; W Löwe; P Persson
Journal:  Pflugers Arch       Date:  1985-09       Impact factor: 3.657

Review 5.  Classical Renin-Angiotensin system in kidney physiology.

Authors:  Matthew A Sparks; Steven D Crowley; Susan B Gurley; Maria Mirotsou; Thomas M Coffman
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

Review 6.  The role of renal nerve stimulation in percutaneous renal denervation for hypertension: A mini-review.

Authors:  Hui-Chun Huang; Hao-Min Cheng; Yook-Chin Chia; Yan Li; Huynh Van Minh; Saulat Siddique; Apichard Sukonthasarn; Jam Chin Tay; Yuda Turana; Narsingh Verma; Kazuomi Kario; Tzung-Dau Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-09       Impact factor: 2.885

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.